Biotech Values

[dewophile]

Yes; however, the HBs seroconverion makes an off-therapy relapse considerably less likely than merely having undetectable HBsAg at the end of treatment

https://events-distribution.easl.eu/from.storage?image=XuxJjSOSJud6SrESrXs_xT__lX7lqBfPJM3PwfWfYrLmyADi8_WVcpnWMbrjgdUZ0

Of the 11 with HBsAg loss, 6 participants...sustained HBsAg loss and
remained anti-HBs positive for at least 24 weeks post-EOT. Among those who achieved
HBsAg loss, anti-HBs titers > 500 mIU/mL at EOT predicted achieving sustained loss of
HBsAg at 24 weeks post-EOT.